Definitive Contract HHSN268201600013C
Award Date
3/1/16
Potential Completion Date
9/7/23
Potential Value
$3.4M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Sri International
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
West Menlo Park, CA 94025, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,327,796.91, was issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to SRI International, a non-profit research and development institute, for biomedical research and development (R&D) in the basic research domain. The contract does not have a set-aside designation. SRI International, as the prime contractor, will perform the...
This is a Cost Plus Fixed Fee contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the Department of Health and Human Services (HHS), to SRI International, a non-profit research and development institute. The $4,294,728.29 contract is for biomedical research and exploratory development in the area of pharmacology and toxicology. It does not have a small business set-aside. The contract includes a subcontract to Charles River Laboratories Ashland, LLC to conduct...
This is a federal contract awarded by the National Cancer Institute, a component of the Department of Health and Human Services, to SRI International, a non-profit research and development institute. The contract is for the synthesis of non-GMP (non-Good Manufacturing Practice) small molecules, with a total ceiling value of $5,499,854.59. The contract type is Cost Plus Fixed Fee, and the ultimate completion date is June 30, 2012. SRI International has a history of supporting federal agencies...
This is a cost-plus-fixed-fee definitive contract awarded by the U.S. government to Sri International, a non-profit research and development institute. The $5,473,276.00 contract is for biomedical research and development services. Sri International has expertise across various disciplines and regularly performs research and development work for federal agencies like the Department of Defense, NASA, Department of Health and Human Services, and Department of Education. The contract does not...
This is a $775,970.20 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services (HHS), to SRI International, a non-profit research and development organization. The contract is related to ARRA (American Recovery and Reinvestment Act) funding and supports the NICHD's Biological Testing Facility. It does not have a small business set-aside designation. SRI...
This is a $748,053.07 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services. The contract was awarded to Sri International, a non-profit research and development institute, to conduct medical and biomedical applied research and exploratory development. This work falls under the agency's Biological Testing Facility major program. The contract does not have a...
This is a $7,910,623.00 cost-plus-fixed-fee contract awarded by the National Cancer Institute (part of the U.S. Department of Health and Human Services) to SRI International, a non-profit research and development institute. The contract is for analysis of anti-cancer chemicals and pharmaceutical formulations. It does not have a small business set-aside designation. SRI International frequently serves as a prime contractor and subcontractor on research and development contracts and grants with...
This is a $67,787,765.29 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI) to SRI International, a non-profit research and development institute, for preclinical toxicology and pharmacology of drugs. The contract supports biomedical research and drug development services for the NCI. SRI International has multiple indefinite delivery vehicles (IDVs) with federal agencies like the Department of Defense, NASA, and the National Institutes of Health that enable efficient...
This federal contract award, valued at $773,798.26, was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to SRI International, a non-profit research and development institute. The contract is for Task Order 27 under a larger indefinite delivery vehicle (IDV), focused on drug product manufacture for ongoing clinical development. This is a cost-plus-fixed-fee contract with no set-aside designation. SRI International has a history of providing...
This is a $3,996,672.79 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to SRI International, a non-profit research and development organization. The contract provides for biological testing facility services, including preclinical studies, drug discovery, and public health initiatives, in support of the American Recovery and Reinvestment Act (ARRA). SRI International has multiple indefinite...